CompletedNot applicableNCT00563251

Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow Transplantation

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Authority, Hong Kong
Principal Investigator
Albert Lie, Dr
Department of Medicine, Queen Mary Hospital/ The University of Hong Kong
Intervention
Azithromycin(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
20052007

Study locations (1)

Collaborators

The University of Hong Kong · Pfizer

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00563251 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials